S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

NCT00041132 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: doxorubicin
DRUG: leucovorin
DRUG: methotrexate
DRUG: vincristine

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]